Five Prime Therapeutics (FPRX) PT Lowered to $60 at Citi
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Price: $38.00 --0%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Citi lowered its price target on Five Prime Therapeutics (NASDAQ: FPRX) to $60.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Bank Central Asia Tbk (BBCA:IJ) (PBCRY) PT Raised to INR7,630 at Macquarie
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
